New treatment option for Atrial Fibrillation
Official title Diagnosis of Postoperative Atrial Fibrillation by a Smartwatch
ClinicalTrials.gov ID: NCT05573633
What this study is testing
- What it's testing
- The incidence of postoperative atrial fibrillation (POAF) after on-pump cardiac surgery remains high, at around 30%. POAF increases the risk of cardiac decompensation, stroke, acute myocardial infarction, and death, resulting in increased morbidity and mortality, hospital length of stay, and cost of patient management.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patient (\>18 years old)
- The patient was hospitalized at Amiens University Hospital for on-pump cardiac surgery.
- The patient has had a recent on-pump cardiac surgery (\< 96h)
- Patient with the motor and cognitive abilities to perform a 1-lead ECG with the smartwatch
- The patient was transferred to the cardiac surgery department of Amiens University Hospital.
You likely can't join if
- History of AF
- Need for rhythmic monitoring by telemetry in cardiac intensive care for atrioventricular block and rapid supra and ventricular rhythm disorder (\>140...
- An external pacemaker connected to epicardial electrodes depends on ventricular and atrial pacing.
- Patients already included in an treatment clinical research protocol may alter the incidence of POAF.
- Pregnant woman
See the full eligibility criteria
- Adult patient (\>18 years old)
- The patient was hospitalized at Amiens University Hospital for on-pump cardiac surgery.
- The patient has had a recent on-pump cardiac surgery (\< 96h)
- Patient with the motor and cognitive abilities to perform a 1-lead ECG with the smartwatch
- The patient was transferred to the cardiac surgery department of Amiens University Hospital.
- The beneficiary of a social security plan
- Signature of the consent to participate in the study
- History of AF
- Need for rhythmic monitoring by telemetry in cardiac intensive care for atrioventricular block and rapid supra and ventricular rhythm disorder (\>140 bpm).
- An external pacemaker connected to epicardial electrodes depends on ventricular and atrial pacing.
- Patients already included in an treatment clinical research protocol may alter the incidence of POAF.
- Pregnant woman
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.